Lumos Pharma | NLNK - Текущие активы



Текущие активы Изменить Дата
Agenus USD 95.28M 38.15M 2026-03
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Capricor Therapeutics USD 283.09M 39.85M 2026-03
Celldex Therapeutics USD 459.22M 75.44M 2026-03
Cipla INR 241.47B 7.71B 2026-03
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 148.02M 59.1M 2025-12
CSL USD 11.85B 1000K 2025-12
Eli Lilly USD 54.84B 794M 2026-03
Grifols EUR 5.96B 316.31M 2025-12
Incyte USD 5.48B 460.36M 2026-03
Intrexon USD 23.72M 45.04M 2024-06
Merck USD 35.02B 8.5B 2026-03
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Pfizer USD 42.82B 76M 2026-03
Prothena USD 339.2M 24.01M 2026-03
Sarepta Therapeutics USD 2.31B 228.06M 2026-03